Campbell & CO Investment Adviser LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$749,618
+251.9%
46,416
+1413.9%
0.09%
+57.9%
Q2 2022$213,000
-60.6%
3,066
-57.4%
0.06%
-69.2%
Q4 2021$541,000
+87.8%
7,200
+453.8%
0.18%
+55.5%
Q2 2021$288,000
+20.0%
1,300
-54.4%
0.12%
+60.8%
Q4 2019$240,000
-0.4%
2,848
-25.2%
0.07%
-32.1%
Q2 2019$241,0000.0%3,805
-50.6%
0.11%
-41.1%
Q2 2018$241,0007,7000.18%
Other shareholders
NOVOCURE LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$77,833,00015.51%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Darsana Capital Partners LP 700,000$155,274,0004.42%
MORGAN JESS S & CO INC 23,775$5,274,0003.47%
Soleus Capital Management, L.P. 98,975$21,955,0003.38%
Montanaro Asset Management Ltd 116,650$25,875,0003.26%
Taylor Frigon Capital Management LLC 31,035$6,884,0002.15%
Rhenman & Partners Asset Management AB 120,000$26,618,0001.81%
COURAGE CAPITAL MANAGEMENT LLC 10,000$2,218,0001.33%
Derbend Asset Management 5,789$1,284,0001.20%
View complete list of NOVOCURE LTD shareholders